0.3399
Milestone Scientific Inc. stock is traded at $0.3399, with a volume of 74,414.
It is down -0.03% in the last 24 hours and up +4.04% over the past month.
Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates through dental and medical segments. Its products include CompuDent System used to control the flow rate of the anesthesia during the injection that allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns; and CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances. CompuFlo also includes a disposable injection handpiece for the tactile control during the injection; CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications; CompuFlo Intra-Articular, a computer controlled injection system for administering corticosteroids and other medicaments; CompuMed for use in various applications, such as plastic, hair restoration, podiatry, colorectal, dermatology, orthopedics, and various other surgeries. Its products also comprising Cosmetic Botulinum Injection device for the pain free injection of botulinum toxin; Veterinary Nerve Block Anesthesia device; the Wand Single Tooth Anesthesia System; and other devices. Milestone Scientific, Inc. was founded in 1989 and is headquartered in Livingston, New Jersey.
See More
Previous Close:
$0.34
Open:
$0.3378
24h Volume:
74,414
Relative Volume:
0.04
Market Cap:
$29.94M
Revenue:
$8.90M
Net Income/Loss:
$-4.57M
P/E Ratio:
-6.1133
EPS:
-0.0556
Net Cash Flow:
$-1.84M
1W Performance:
-12.82%
1M Performance:
+4.04%
6M Performance:
-3.16%
1Y Performance:
-60.71%
Milestone Scientific Inc. Stock (MLSS) Company Profile
Name
Milestone Scientific Inc.
Sector
Industry
Phone
973-535-2717
Address
220 South Orange Avenue, Livingston, NJ
Compare MLSS vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MLSS
Milestone Scientific Inc.
|
0.3399 | 29.77M | 8.90M | -4.57M | -1.84M | -0.0556 |
|
ISRG
Intuitive Surgical Inc
|
402.18 | 147.53B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
141.61 | 40.10B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
64.14 | 32.33B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
36.42 | 31.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
186.29 | 27.96B | 5.54B | 1.52B | 1.74B | 10.37 |
Milestone Scientific Inc. Stock (MLSS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-16-20 | Initiated | Northland Capital | Market Perform |
| Nov-16-18 | Reiterated | Maxim Group | Buy |
| Dec-23-16 | Reiterated | Maxim Group | Buy |
| Dec-11-15 | Initiated | Maxim Group | Buy |
Milestone Scientific Inc. Stock (MLSS) Latest News
MLSS Q1 2026 Earnings: Narrower-Than-Expected Loss and Positive SurpriseBalance Sheet Strength - newsline.com
Milestone Scientific (MLSS) Q1 2026 Earnings: Narrower-than-Expected Loss Per ShareBook Value Growth - newsline.com
SpaceX Shares Surge 11% in Nasdaq Debut After Landmark $75 Billion IPOPreliminary Results - newsline.com
NASA’s experimental quiet supersonic plane passes another critical milestone - Scientific American
Milestone Scientific (MLSS) Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock HigherROA Comparison - newsline.com
Milestone Scientific (MLSS) asks shareholders to expand share authorization and equity plan - Stock Titan
[EFFECT] MILESTONE SCIENTIFIC INC. SEC Filing - Stock Titan
World Dental Anesthesia Delivery SystemsMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Milestone Scientific (MLSS) registers 15.9M shares; warrants exercisable at $0.3375 - Stock Titan
Milestone Scientific (MLSS) asks shareholders to increase authorized shares and equity plan - Stock Titan
DiagnosTear Achieves Major Scientific Milestone with Publication of TeaRx(TM) Clinical Study in Current Eye Research Journal - TMX Newsfile
Milestone Scientific approves stock option repricing and new performance-based awards - Investing.com
MLSS: Selling Stockholder to Offer Nearly 8 Million Shares - GuruFocus
Milestone Scientific (NYSE American: MLSS) registers 15.9M shares from April 2026 placement - Stock Titan
Amazon Stock Could Reach $300 This Year: Key Drivers from Yahoo Finance AnalysisConsensus Beat Rate - The Legal Advocate
Japan hits 6G key milestone with high-frequency speeds topping 100 Gbps - Live Science
Milestone Scientific (MLSS) Rallies 3.9% as Shares Approach Key Resistance at $0.42Calendar Spread Trade - newsline.com
Milestone Scientific’s CompuFlo® Technology Sees Increased Physician Adoption Due to Real-Time Pressure Sensing - geneonline.com
Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures - The Manila Times
Milestone Scientific Inc. Reports Increased Adoption of CompuFlo® Epidural System Following Positive Research Findings from University of Texas Medical Branch - Quiver Quantitative
Epidural-guiding device cuts SCS complications by 91% in UTMB study - Stock Titan
Asahi Kasei Life Science Acquires License for Novel Antibody-Drug Conjugate Technology from The Noguchi Institute – A Major Milestone for More Efficient and Safer Cancer Treatments - Business Wire
Milestone Scientific (MLSS) Q1 2026 Earnings: Narrower Loss Beats Estimates as Stock Edges LowerOpen Signal Network - Newser
MLSS Q1 2026 Earnings: Narrower-Than-Expected Loss Per ShareDividend Growth Analysis - newsline.com
MLSS Q1 2026 Earnings: Narrower-Than-Expected Loss as Commercial Efforts ContinueEarnings Revision Downgrade - The Legal Advocate
NTHI Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Focuses on Pipeline Development - The Legal Advocate
Benchmark reiterates Milestone Scientific stock rating on revenue guidance By Investing.com - Investing.com Nigeria
Benchmark reiterates Milestone Scientific stock rating on revenue guidance - Investing.com
Milestone Scientific (MLSS) price target decreased by 50.00% to 1.02 - MSN
Milestone Scientific (MLSS) Up +1.01% — Is There More Room to Run? 2026-05-18Volume Climax - The Legal Advocate
Milestone Scientific, Inc. Common Stock (NY: MLSS - FinancialContent
Thermo Fisher Deepens Oncology Role With Ibtrozi Manufacturing Milestone - Yahoo Finance
Maxim Group Maintains Milestone Scientific(MLSS.US) With Buy Rating, Maintains Target Price $1 - Moomoo
Milestone Scientific Inc (MLSS) Q1 2026 Earnings Call Highlights: Strategic Growth Amid Global Challenges - GuruFocus
Milestone Scientific Earnings Call Signals Cautious Upswing - TipRanks
Milestone Scientific Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Earnings Call Summary | Milestone Scientific(MLSS.US) Q1 2026 Earnings Conference - Moomoo
MLSS Projects Strong Revenue Growth Through 2026 - GuruFocus
Earnings call transcript: Milestone Scientific Q1 2026 beats EPS expectations By Investing.com - Investing.com Nigeria
Earnings call transcript: Milestone Scientific Q1 2026 beats EPS expectations - Investing.com
Milestone Scientific (MLSS) Reports Q1 Revenue Challenges with P - GuruFocus
Full Transcript: Milestone Scientific Q1 2026 Earnings Call - Benzinga
Milestone Scientific stock surges 9% on narrower loss By Investing.com - Investing.com South Africa
Milestone Scientific Q1 revenue steady, operating loss narrows - TradingView
Milestone Scientific stock surges 9% on narrower loss - Investing.com UK
Milestone Scientific Reports Financial Results for First Quarter 2026 - marketscreener.com
Milestone Scientific Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026 - marketscreener.com
Milestone Scientific earnings beat by $0.01, revenue fell short of estimates - Investing.com Canada
Milestone Scientific Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Milestone Scientific (MLSS) trims Q1 2026 loss but flags going concern and NYSE listing risks - Stock Titan
Earnings call transcript: Core Scientific Q1 2026 reveals mixed performance - Investing.com
Milestone Scientific Inc. Stock (MLSS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):